Literature DB >> 17072541

Prevalence of human papilloma virus infection in women in rural Ethiopia.

R Ruland, C Prugger, R Schiffer, M Regidor, R J Lellé.   

Abstract

In Ethiopia cervical carcinoma is the most frequent cancer in women. HPV infection is a prerequisite for this disease. However, to date there have been no data on human papilloma virus (HPV) prevalence in Ethiopia. Outpatients attending Attat hospital in rural Ethiopia were examined for the presence of HPV DNA using the Digene HPV test. 15.9% of patients were found to be HPV positive. The proportion of HPV high risk types was 13.2% [age-standardised rates: HPV: 14.4% (95% CI: 8.5-20.2); HPV high risk: 11.6% (95% CI: 6.3-16.9)]. Compared to other countries HPV prevalence is high, especially of high risk types. Until vaccination programmes take effect, screening programmes should not be based on HPV testing alone as this will lead to significant overtreatment of healthy women.

Entities:  

Mesh:

Year:  2006        PMID: 17072541     DOI: 10.1007/s10654-006-9055-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  Detection of high-risk HPV types by the hybrid capture 2 test.

Authors:  G Terry; L Ho; P Londesborough; J Cuzick; I Mielzynska-Lohnas; A Lorincz
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

2.  The promise of global cervical-cancer prevention.

Authors:  Mark Schiffman; Philip E Castle
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

3.  A follow-up of repair of ruptured uterus in Ethiopia.

Authors:  J Kelly; S Fekadu; R J Lancashire; P Poovan; A Redito
Journal:  J Obstet Gynaecol       Date:  1998-01       Impact factor: 1.246

Review 4.  HPV-mediated cervical carcinogenesis: concepts and clinical implications.

Authors:  Peter J F Snijders; Renske D M Steenbergen; Daniëlle A M Heideman; Chris J L M Meijer
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

5.  Cost-effectiveness of cervical-cancer screening in five developing countries.

Authors:  Sue J Goldie; Lynne Gaffikin; Jeremy D Goldhaber-Fiebert; Amparo Gordillo-Tobar; Carol Levin; Cédric Mahé; Thomas C Wright
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

6.  Evaluation of alternative methods of cervical cancer screening for resource-poor settings.

Authors:  L Denny; L Kuhn; A Pollack; H Wainwright; T C Wright
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

7.  Direct visual inspection of the cervix for the detection of premalignant lesions.

Authors:  Amr El-Shalakany; Sabry S Hassan; Essam Ammar; Mohammad A Ibrahim; Magda Abdel Salam; Mohammad Farid
Journal:  J Low Genit Tract Dis       Date:  2004-01       Impact factor: 1.925

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.

Authors:  P S Basu; R Sankaranarayanan; R Mandal; C Roy; P Das; D Choudhury; D Bhattacharya; R Chatterjee; K Dutta; S Barik; V Tsu; R N Chakrabarti; M Siddiqi
Journal:  Int J Gynecol Cancer       Date:  2003 Sep-Oct       Impact factor: 3.437

10.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

View more
  8 in total

Review 1.  Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia.

Authors:  TeweldeTesfaye Gebremariam
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

2.  Health seeking behavior for cervical cancer in Ethiopia: a qualitative study.

Authors:  Zewdie Birhanu; Alemseged Abdissa; Tefera Belachew; Amare Deribew; Hailemariam Segni; Vivien Tsu; Kim Mulholland; Fiona M Russell
Journal:  Int J Equity Health       Date:  2012-12-29

3.  The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study.

Authors:  Mona M Rashed; Alemayehu Bekele
Journal:  Pan Afr Med J       Date:  2011-03-11

4.  Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia.

Authors:  Sami-Ramzi Leyh-Bannurah; Christof Prugger; Maurits Nc de Koning; Hartmut Goette; Ralph J Lellé
Journal:  Infect Agent Cancer       Date:  2014-10-08       Impact factor: 2.965

5.  HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia.

Authors:  Dawit Wolday; Muluken Derese; Solomon Gebressellassie; Bekure Tsegaye; Wondwossen Ergete; Yirgu Gebrehiwot; Orit Caplan; Dana G Wolf; Shlomo Maayan
Journal:  Infect Agent Cancer       Date:  2018-08-14       Impact factor: 2.965

6.  HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.

Authors:  Eshetu Lemma Haile; Simoens Cindy; Benoy Ina; Gurja Belay; Van Geertruyden Jean-Pierre; Ransom Sharon; Lebelo Ramokone Lisbeth; Bogers Johannes Paul
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.

Authors:  Minwuyelet Maru Temesgen; Tefera Alemu; Birtukan Shiferaw; Seid Legesse; Taye Zeru; Mahteme Haile; Tesfaye Gelanew
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

8.  Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis.

Authors:  Ayele Semachew Kasa; Tadesse Dagget; Yeshiwork Beyene; Getnet Dessie; Aklilu Endalamaw; Yinager Workineh; Emiru Ayalew; Balew Zeleke; Sitotaw Kerie; Getasew Mulat; Worku Animaw
Journal:  Syst Rev       Date:  2021-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.